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Background: Pain catastrophizing (PC) is associated with more severe and disabling migraine attacks. However,
factors that moderate this relationship are unknown. Failure of inhibitory control (IC), or the ability to suppress
automatic or inappropriate responses, may be one such factor given previous research showing a relationship
between higher PC and lower IC in non-migraine samples, and research showing reduced IC in migraine. Therefore,
we examined whether lower IC interacts with increased PC to predict greater migraine severity as measured by
pain intensity, attack frequency, and duration.
Methods: Women (n = 105) aged 18–50 years old (M = 38.0 ± 1.2) with overweight/obesity and migraine who were
seeking behavioral treatment for weight loss and migraine reduction completed a 28-day smartphone-based
headache diary assessing migraine headache severity. Participants then completed a modified computerized Stroop
task as a measure of IC and self-report measures of PC (Pain Catastrophizing Scale [PCS]), anxiety, and depression.
Linear regression was used to examine independent and joint associations of PC and IC with indices of migraine
severity after controlling for age, body mass index (BMI) depression, and anxiety.
Results: Participants on average had BMI of 35.1 ± 6.5 kg/m2and reported 5.3 ± 2.6 migraine attacks (8.3 ± 4.4 migraine
days) over 28 days that produced moderate pain intensity (5.9 ± 1.4 out of 10) with duration of 20.0 ± 14.2 h. After
adjusting for covariates, higher PCS total (β = .241, SE = .14, p = .03) and magnification subscale (β = .311, SE = .51,
p < .01) scores were significant independent correlates of longer attack duration. IC interacted with total PCS (β = 1.106,
SE = .001, p = .03) rumination (β = 1.098, SE = .001, p = .04), and helplessness (β = 1.026, SE = .001, p = .04) subscale
scores to predict headache pain intensity, such that the association between PC and pain intensity became more
positive at lower levels of IC.
Conclusions: Results showed that lower IC interacted with higher PC, both overall and specific subcomponents, to
predict higher pain intensity during migraine attacks. Future studies are needed to determine whether interventions to
improve IC could lead to less painful migraine attacks via improvements in PC.
Keywords: Migraine, Overweight, Obesity, Inhibitory control, Pain catastrophizing* Correspondence: Rachel.Galioto@lifespan.org
1Department of Psychiatry and Human Behavior, Alpert Medical School of
Brown University, Providence, RI, USA
2Rhode Island Hospital, Providence, RI, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Galioto et al. The Journal of Headache and Pain  (2017) 18:41 Page 2 of 8Background
Migraine is a prevalent neurologic disease characterized
by severe recurrent headache pain [1] and is associated
with substantial functional and quality of life impairments
[2]. Psychological factors, particularly those specific to
pain, are known to contribute to greater migraine severity
(i.e., pain intensity, attack frequency, and duration). Spe-
cifically, pain catastrophizing, which is defined as a nega-
tive mental set in response to pain involving difficulty
inhibiting pain related thoughts (rumination), exaggerat-
ing the negative consequences of pain (magnification),
and negatively evaluating one’s ability to cope with pain
(helplessness) [3, 4], is associated with migraine attacks
that are more frequent, severe, and longer in duration,
and with greater headache-related disability and impair-
ments in quality of life [5–7]. Additionally, individuals
with clinically significant levels of pain catastrophizing are
at greater risk for chronic migraine [5].
While the above findings demonstrate the importance
of pain catastrophizing in the context of migraine, very
little is known about factors that contribute to higher
levels of pain catastrophizing in individuals with migraine.
It is possible that lower inhibitory control, defined as abil-
ity to suppress automatic and/or inappropriate thoughts
or behaviors, may influence the frequency or degree of
pain catastrophizing in persons with migraine. Specifically,
lower inhibitory control may make it more difficult for
participants to control pain-related thoughts, resulting in
thoughts that are more uncontrollable. This notion is sup-
ported by findings in one study of adolescents that found
that lower inhibitory control, as rated by a self-report
questionnaire, was associated with higher levels of pain
catastrophizing [8]. Additionally, other studies have shown
that poorer inhibitory control is associated with lower
pain tolerance in other clinical samples, [9, 10] while bet-
ter inhibitory skills are associated with lowered pain per-
ception [9]. However, these studies were not conducted in
the context of migraine.
The relationship between inhibitory control and pain cat-
astrophizing may be particularly salient among individuals
with migraine given that migraine is associated with frontal
lobe abnormalities, a region implicated in inhibitory con-
trol [11, 12], including greater volume of white matter
hyperintensities, reduced white matter structural integrity,
and lower gray and white matter volume [13–18]. More-
over, recent work among individuals with migraine shows
an association between higher levels of pain catastrophiz-
ing and brain abnormalities in areas associated with pain
processing [19]; the areas involved overlap with those im-
plicated in inhibitory control (i.e., prefrontal cortex; e.g.,
[11, 12]). Despite these possible links between inhibitory
control and pain catastrophizing in migraine, no study has
directly explored this potential interaction in relation to
migraine pain intensity, duration, and frequency.Therefore, the purpose of the current study is to
examine whether inhibitory control interacts with pain
catastrophizing to predict migraine pain intensity, attack
frequency and duration in women with migraine and
overweight/obesity after controlling for age, anxiety, de-
pression, and body mass index (BMI). It is hypothesized
that lower inhibitory control, measured objectively using
a computerized Stroop task, will interact with higher pain
catastrophizing, measured by the Pain Catastrophizing
Scale [3]), to influence migraine pain intensity, attack fre-
quency, and duration. If supported, this would have im-
portant treatment and research implications given that
impaired inhibitory control can be improved through
training [20–22]. This, in turn, could diminish the impact




The current study is an analysis of baseline data from the
Women’s Health and Migraine (WHAM) trial (clinicaltrials.
gov NCT01197196) [23]. Participants included 128 women
aged 18 to 50 who were overweight or obese (BMI= 25.0-
49.9 kg/m2) with a neurologist-confirmed migraine diagnosis
based on the International Classification of Headache
Disorders (3rd Edition beta criteria), [1] who sought be-
havioral weight loss treatment to reduce their migraine
headaches. Participants were not currently pregnant or
nursing and had not changed or initiated medications
used to treat migraine attacks, depression, or contra-
ception within two months prior to beginning the trial.
Once informed consent was provided, participants
completed a diagnostic evaluation by a board-certified
neurologist to confirm their migraine diagnosis and to
determine the onset of their migraines. Lastly, partici-
pants had their weight status and baseline preventative
medication usage confirmed by study personnel, completed
questionnaires, which assessed both psychological variables,
including pain catastrophizing, and demographic char-
acteristics, and were instructed on completing a 28-day
headache diary. Once the 28-day diary was completed
and verified by study staff, participants returned to the
research center and completed the computerized version
of the Stroop task. The study protocol was approved by
the Rhode Island Hospital Institutional Review Board
(Providence, RI, USA).
Measures
Headache characteristics and clinical features
Daily headache monitoring A web-based headache
diary application, designed by the research team for use
on smartphones [23], was used to record participants’
migraine headaches data prior to bedtime for 28 consecu-
tive days. All ratings were automatically transmitted to the
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occurrence (yes/no), maximum headache pain intensity
(0 “no pain” to 10 “pain as bad as you can imagine”),
and duration (hours). Research staff conducted daily
checks to determine if headache data was complete (if
not, participants were contacted to complete needed in-
formation). For the purposes of the present study, par-
ticipant data were summarized as frequency (assessed
as number of migraine days/mo.), average maximum
pain intensity, and average duration of individual attacks.
Participants also provided information about their abort-
ive medication usage during the headache monitoring
period.
Pain Catastrophizing
Pain Catastrophizing Scale (PCS) The 13-item PCS
was used to measure catastrophic thinking related to
pain [3]. The PCS generates a total score and 3 subscale
scores including rumination, magnification, and help-
lessness during the experience ofpain in previous month.
PCS total scores range from 0 to 52, with higher scores
indicating greater pain catastrophizing. The PCS has
established reliability and construct validity and has pre-
viously been used to evaluate levels of pain catastrophiz-
ing in individuals with migraine [3, 5, 7, 24].
Inhibitory Control
Modified Stroop The modified Stroop task assesses in-
hibitory control and was conducted using Eprime Stimu-
lus Presentation Software (Psychology Software Tools,
Pittsburgh, PA). The test is comprised of three condi-
tions: Word, Color, and Color-Word. In the Word con-
dition, participants responded to the meaning of a target
word (i.e., ‘red,’ ‘green,’ or ‘blue’ displayed in black), as
quickly as possible. In the Color condition, participants
responded to the colors in which an array of X’s were
displayed (i.e., XXXX displayed in red), as quickly as
possible. The Color and Word conditions assess process-
ing speed. In the Color-Word condition, participants
responded to the colors in which an incongruent color
word were displayed (i.e., ‘RED’ displayed in green), as
quickly as possible. The Color-Word condition assesses
inhibitory control as participants must suppress the re-
sponse of reading the word [25, 26]. Participants completed
three 45-s blocks of each condition, in a counterbalanced
order. For each condition, all targets were displayed until
the participant provided a response. The reaction time (in
milliseconds) for correct responses in the Color-Word
condition was used as the measure of inhibitory control.
Anthropometric characteristics
Height and weight were measured using a wall-mounted
Harpenden stadiometer (Holtain, Ltd., Crosswell, Crymyh,
Pembs, UK) and calibrated digital scale (Tanita BWB 800:Tanita Corporation of America, Inc, Arlington Heights,
IL, USA). Body mass index (BMI) was calculated from
these measures using the formula: BMI (kg/m2) = weight
(kg)/(height [m])2.
Demographic characteristics
Age, marital status, race, ethnicity, and level of education
were assessed via questionnaire.
Psychological characteristics
Depression The 20-item Center for Epidemiologic Studies
Depression Scale (CES-D) assessed frequency of depressive
symptoms over the past week [27]. CES-D scores range
from 0 to 60 with higher scores indicating more severe de-
pressive symptoms. Clinically significant depressive symp-
toms are scores that are ≥ 16. The CES-D has high internal
consistency, reliability, and both predictive and concurrent
validity with respect to pain [27, 28].
Anxiety The 7-item Generalized Anxiety Disorder Scale
(GAD-7) assessed severity of anxiety symptoms over the
previous 2-week period [29]. Higher scores are indicative
of greater levels of anxiety symptoms, with scores of 5,
10, and 15 serving as cutoff points for mild, moderate
and severe anxiety symptoms, respectively. This measure
is shown to accurately and reliably assess anxiety in pri-
mary care settings and the general population [29, 30].
Statistical analyses
Descriptive statistics were generated to characterize the
sample. Bivariate correlations, independent samples t-tests,
and one-way analyses of covariance (ANOVA) were con-
ducted to examine associations between demographic vari-
ables and inhibitory control to determine covariates for
inclusion in the primary analysis. As a result, age was en-
tered as a covariate in subsequent analyses. It is important
to note that initial onset of migraine and use of pre-
ventative or abortive medications during the headache
monitoring period were not associated with pain cata-
strophizing (total or subscale scores) or inhibitory con-
trol, and were therefore not included as covariates.
Additional covariates included, depression and anxiety,
to enable clearer examination of the potential influence
of pain catastrophizing, independently or in conjunc-
tion with inhibitory control, and BMI, due its known
association with pain catastrophizing [5, 31] and inhibi-
tory control [32, 33]. Separate linear regression models
were conducted to examine the independent and joint
associations of pain catastrophizing (total score and
subscales) and inhibitory control (Stroop Color Word
RT) with each of the migraine severity components (i.e.
pain intensity, attack frequency and duration). All tests
of statistical significance were two-tailed and tolerance
for Type 1 error was set at α = 0.05. This study involved
Table 1 Characteristics of the sample
Demographic and anthropometric characteristics
Age, years, mean (SD) 38.0 (1.2)




Ethnicity (% of participants)
Non-Hispanic 84.0%
Hispanic 16.0%
Education (% of participants)




Body mass index, kg/m2, mean (SD) 35.1 (6.5)
Migraine Initial Onset (% of participants)
Childhood 39.3%
Teenage years 26.2%
Early Adulthood (20’s – 30’s) 31.8%
Over age 40 2.8%
Migraine Severity
Migraine Parameters
Frequency, mean (SD) days/mo. (# episodes) 5.5 (2.6)
Migraine Days, mean (SD) 8.4 (4.4)
Intensity, mean (SD) on scale of 1 to 10 5.9 (1.4)
Duration, mean (SD) hours 20.0 (14.2)
Medication Use (% of participants using)






Pain Catastrophizing (mean, SD)





Stroop Color-Word Reaction Time, mean (SD) msec 1203.5 (275.8)
Stroop Color-Word (% correct responses) 93.8 (0.1)
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of an ongoing randomized controlled trial.
Results
Characteristics of the sample
Twenty-one individuals were excluded from analyses
due to their poor performance level (i.e., <50% correct
responses on the Stroop Color-Word test); participants
were excluded as poor performance may have been due
to reduced effort or understanding of the task and the
cut-off used is similar to previous studies using similar
cognitive tasks [34–36]. An additional 2 participants were
excluded for not completing the 28-day headache protocol,
resulting in a total sample of 105 participants. Table 1 shows
demographic, anthropometric, and pain catastrophizing
scores of the sample. On average, participants were 38 years
of age with severe obesity (MBMI = 35.1 ± 6.5 kg/m
2).
Approximately one-fifth (20.8%) of participants were
non-White and 16.0% were Hispanic. The majority of
participants had a college degree (40.6%) or had completed
some college (30.2%) while 18.9% completed additional
graduate/professional training; 10.2% of participants had a
high school degree or less than 12 years of education. On
average, participants reported having a migraine attack on
8 days over the 28-day monitoring period and rated the
maximum pain intensity per attack on average as moderate
or 6 out of 10. With respect to initial migraine onset,
39.3% reported during childhood, 26.2% during teenage
years, 31.8% during their 20’s to 30’s, and 2.8% over age 40.
None of the participants reported having a migraine attack
on the day of cognitive testing. Participants averaged
93.8 ± 01% accuracy and 1203.5 ± 275.8 ms reaction
time on the Color-Word condition of the Stroop test.
Of the 105 included participants, 21.5% were using pre-
ventative medications at baseline. Additionally, the vast
majority of participants used abortive medications (90.7%)
during the headache monitoring period including non-
steroidal anti-inflammatory drugs (NSAIDs; 66.4%),
Excedrin (24.3%), Triptan (33.6%), and other medications
(36.4%) which includes opiods (14%), Butalbital (15.9%),
and herbal medications, anti-convulsants, muscle relax-
ants, analgesics, and anti-depressants (.9% each). Inde-
pendent samples t-tests revealed no significant differences
in inhibitory control or pain catastrophizing (total score
and subscales) between individuals with and without aura
(p’s > .31); therefore, these groups were analyzed together.
Independent and joint associations of pain catastrophizing
and inhibitory control with migraine severity components
Regression models examined independent and joint as-
sociations of pain catastrophizing and inhibitory control
with 3 indices of migraine severity (headache pain inten-
sity and attack frequency and duration) controlling for
age, depression, anxiety, and BMI.Migraine Pain Intensity (Table 2 Column 1)
There were no independent associations between inhibi-
tory control or pain catastrophizing and pain intensity
(p’s > .39). However, inhibitory control interacted with
Table 2 Linear regressions examining pain catastrophizing, inhibitory control, and their interactions in relation to migraine severity
as measured by attack frequency, pain intensity and duration
Pain Intensity Duration Attack Frequency
B SE β p R2 B β SE p R2 B β SE p R2
PCS Total .12 .11 .13
Age .0003 .02 .002 .99 -.15 .18 -.09 .40 -.06 .05 -.12 .26
BMI -.03 .02 -.13 .22 -.29 .23 -.13 .20 -.12 .07 -.17 .09
Depression .01 .04 .04 .73 .15 .41 .05 .71 .15 .13 .15 .23
Anxiety .05 .04 .15 .22 .20 .37 .06 .60 .16 .11 .17 .16
PCS-Total -.10 .06 -.78 .08 .05 .57 .04 .93 -.24 .18 -.60 .17
IC -.002 .001 -.33 .10 -.001 .01 -.03 .90 -.003 .003 -.17 .40
PCS-Total*IC .0001 .00005 1.02 .04 .0002 .0005 .23 .64 .0002 .0001 .63 .19
Rumination .11 .09 .16
Age -.001 .02 -.008 .94 -.17 .18 -.10 .34 -.06 .05 -.11 .26
BMI -.03 .02 -.11 .28 -.30 .23 -.14 .19 -.11 .07 -.16 .12
Depression .02 .04 .05 .68 .20 .42 .06 .64 .15 .12 .14 .23
Anxiety .05 .04 .15 .22 .22 .38 .07 .55 .17 .11 .18 .12
Rumination -.30 .16 -.91 .06 -.89 1.58 -.27 .58 −1.00 .47 -.97 .18
IC -.002 .001 -.34 .11 -.005 .01 -.10 .64 -.004 .003 -.28 .18
Rumination*IC .0003 .0001 1.05 .04 .001 .001 .48 .36 .001 .0004 .88 .08
Magnification .12 .14 .13
Age -.001 .02 -.004 .97 -.09 .18 -.05 .61 -.06 .06 -.11 .28
BMI -.02 .02 -.11 .29 -.29 .22 -.13 .19 -.12 .07 -.18 .08
Depression .02 .04 .05 .70 .04 .41 .01 .92 .15 .13 .14 .24
Anxiety .05 .04 .16 .17 .19 .36 .06 .61 .16 .11 .16 .17
Magnification -.30 .20 -.64 .15 -.43 2.02 -.09 .83 -.78 .63 -.53 .23
IC -.001 .001 -.18 .22 -.004 .008 -.08 .58 -.002 .002 -.10 .52
Magnification*IC .0003 .0002 .86 .07 .002 .002 .44 .34 .001 .0005 .61 .19
Helplessness .12 .09 .11
Age -.002 .02 -.01 .92 -.21 .18 -.12 .26 -.07 .06 -.12 .24
BMI -.03 .02 -.12 .26 -.22 .23 -.10 .33 -.12 .07 -.17 .10
Depression .02 .04 .05 .65 .24 .41 .07 .56 .16 .13 .15 .22
Anxiety .05 .04 .15 .20 .27 .37 .09 .46 .15 .11 .15 .20
Helplessness -.18 .13 -.63 .16 .97 1.30 .33 .46 -.13 .40 -.15 .74
IC -.001 .001 -.26 .18 .006 .01 .11 .57 -.0003 .003 -.02 .92
Helplessness*IC .0002 .0001 .86 .08 -.0003 .001 -.16 .75 .0001 .0003 .21 .66
BMI Body mass index, PCS Pain Catastrophizing Scale, IC Inhibitory Control
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and rumination (β = 1.05, SE = .0001, p = .04) subscale
scores to predict headache pain intensity, such that the as-
sociation between pain catastrophizing and pain intensity
became more positive at lower levels of inhibitory control.
Migraine Attack Duration (Table 2, Column 2)
Higher pain catastrophizing total (β= .241, SE = .14, p= .03)
and magnification subscale (β= .311, SE = .51, p < .01) scores
were significant independent predictors of longer individualattack duration. Measures of inhibitory control and the
interaction of pain catastrophizing with inhibitory control
did not influence average duration of individual mi-
graine attacks (p’s > .34).Migraine Attack Frequency
There were no independent or joint associations for in-
hibitory control and pain catastrophizing in relation to
headache attack frequency (p’s > .08).
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This study examined whether pain catastrophizing inter-
acted with objective measures of inhibitory control to pre-
dict migraine severity components among women with
migraine and overweight/obesity. The primary finding is
that pain catastrophizing [overall and specific sub-
components (i.e. rumination and helplessness)] interacted
with inhibitory control to predict headache pain intensity,
such that increased catastrophizing was associated with
higher levels of pain intensity when inhibitory control was
reduced. In contrast, no interaction between pain cata-
strophizing and inhibitory control was found in relation to
headache frequency or duration of individual headache
attacks.
These findings build on previous research showing
that higher levels of pain catastrophizing are associated
with migraine attacks that are more severe and disabling
[5–7, 37] by highlighting the potential contribution of
poorer inhibitory control. This contribution seems to be
particularly important in the context of degree of pain
intensity within an acute attack. This finding coupled
with the lack of association with attack frequency or
duration suggests that lower inhibitory control exacer-
bates the adverse effect of pain catastrophizing after the
initiation of an attack, but does not necessarily increase
likelihood of attack occurrence or impact pain duration.
Alternatively, it is possible that the interaction of IC and
PC might be stronger in relation to the more subjective
(i.e. degree of perceived pain) versus objective (i.e. occur-
rence and duration of pain) components of migraine
severity.
The present study advances previous work focused on
catastrophizing and/or inhibitory control in the context
of pain [5–10] by demonstrating the interaction of these
variables in relation to frequency, duration, and intensity
of a specific pain condition (migraine). Further, our exam-
ination of the relationship between inhibitory control and
specific components of pain catastrophizing (e.g., ru-
mination) provides greater insight into the inhibitory
control-pain catastrophizing link. Specifically, rumination
in the context of migraine refers to difficulty inhibiting
pain-related thoughts, and it would follow that reduced
inhibitory control might exacerbate this difficulty.
This study also has important clinical implications as
research has shown that inhibitory control may be im-
proved through computerized cognitive training [20–22],
which might help attenuate any adverse effects of pain
catastrophizing on pain intensity. Future studies should
examine whether improvement in inhibitory control
through training could lead to less severe migraine at-
tacks via reduced pain catastrophizing. This study has
several methodological strengths including the large sam-
ple size and the use of smartphone diaries for near real
time monitoring of daily headache activity over a 4-weekperiod. Additionally, the use of computerized measures of
inhibitory control reduces the possibility of measurement
error and bias.
This study must also be viewed in light of certain limi-
tations and considerations for future research. Given the
cross-sectional study design, we cannot infer causality in
the observed associations. Thus, future research involving
prospective designs that can provide insight regarding
causality and underlying mechanisms are needed. Al-
though this sample is advantageous in that higher levels of
pain catastrophizing and lower inhibitory control may be
expected among overweight/obese individuals [5, 31–33],
future studies should examine whether these results
generalize to more diverse samples in terms of weight sta-
tus as well as gender, given that this sample was comprised
solely of female participants. Another limitation is that the
PCS items are not specific to migraine and thus may have
captured other types of pain in addition to migraine. The
presence of other pain-related conditions was not assessed
in this study, which could have affected the results. Add-
itionally, other factors that may contribute to pain catastro-
phizing and inhibitory control in this sample, such as sleep
quality and duration, were not examined; future studies
should examine the observed relationships in the context
of other such factors.
Conclusions
In conclusion, the present study showed that lower inhibi-
tory control interacted with higher levels of pain catastro-
phizing to predict greater pain intensity during migraine
headache attacks. Future prospective studies are needed
to determine whether improvement in inhibitory control
through training could lead to less severe attacks via at-
tenuation of pain catastrophizing.
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